Propofol depresses both cerebral oxygen consumption and glucose utilization. We tested the hypothesis that these well described effects on brain metabolism are manifest by a reduction in neuronal acid production in vitro. The rate of extracellular acidification in primary cell cultures of rat cortical neurones was measured using a novel instrument (silicon microphysiometer) after stimulation with propofol 0.3, 3 and 30 µg ml -1 . Intralipid 10% served as a control. Propofol 3 µg ml -1 caused a mean decrease of 1.51 (SEM 0.71)% in baseline acidification rate, which was significantly greater than that produced by 0.3 µg ml -1 or Intralipid alone (PϽ0.05). The reduction after stimulation with propofol 30 µg ml -1 was 4.68 (0.35)% of baseline rates and this in turn was significantly greater than that elicited by propofol 3 or 0.3 µg ml -1 , or Intralipid (PϽ0.001). We have confirmed the depressant effect of propofol on cerebral metabolism and established that propofol inhibits neuronal acid excretion in vitro.
In vitro studies have demonstrated a positive correlation between the severity and duration of extracellular acidosis and the extent of glial and neuronal damage. 1 Furthermore, pre-ischaemic hyperglycaemia augments ischaemic brain infarction in vivo, 2 suggesting that excess lactic acid production secondary to accelerated anaerobic glycolysis critically contributes to cerebral injury. Together, these observations suggest that pharmacological agents which attenuate cerebral acidosis during ischaemia-hypoxia may provide neuronal protection. In this regard, propofol suppresses electroencephalographic activity and is a cerebral metabolic depressant. As the main products of energy metabolism are hydrogen ions from lactic acid, carbon dioxide and adenosine triphosphate (ATP) hydrolysis, it follows that propofol offers the potential to decrease the rate of extracellular acid production in brain tissue, although this has not been investigated to date.
Silicon microphysiometry is a novel technology which measures the rate of proton efflux from cell cultures in real time, and the rate of extracellular acidification has been shown to correlate well with indices of cellular metabolism. 3 We used a microphysiometer to investigate the effects of increasing concentrations of propofol on extracellular acidification rate in primary tissue cultures.
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Methods and results
This study was approved by the Ethics Committee for Animal Research of Linköping University. Primary cortical cell cultures containing 80% neurones and 20% glial cells were cultivated and prepared from newborn SpragueDawley rats, as detailed by Hansson and Rönnbäck. 4 Cells were cultured in Costar's transwell culture chamber inserts (supplied by Molecular Devices Corporation, CA 94025, USA) and maintained at 37°C for 10-12 days in a humidified incubator with 5% carbon dioxide and 95% air. The capsules were loaded into the flow chambers of a microphysiometer (Molecular Devices Corporation) and examined for responses to propofol 0.3, 3 and 30 µg ml -1 . Intralipid, the solvent for propofol, was used as a control.
The Cytosensor microphysiometer system was used to measure the rate at which cortical neurones acidified their extracellular environment, the operating principle and function of which have been described in detail elsewhere. 3 Briefly, cell cultures are placed in a low-volume flow chamber, one side of which is a silicon-based light addressable potentiometer (LAPS). A photocurrent is generated when the sensor is illuminated with an amplitudemodulated light-emitting diode. The LAPS makes a voltage measurement that is related linearly to pH and the rate of chamber acidification is determined as the slope of a linear least-squares fit to the pH-time data. 5 In the flow chamber of the microphysiometer, cells were perfused with Dulbecco's modified Eagle's medium without sodium bicarbonate (DMEM-high modified, JRH Biosciences), with D-glucose 4.5 g ml -1 , L-glutamine 548 mg ml -1 and sodium pyruvate 110 mg ml -1 . The medium was supplemented with sodium chloride 40 mmol litre -1 (to preserve osmotic balance) and 1% w/v fetal calf serum (Gibco, Grand Island, NY, USA). The buffer capacity of the medium was approximately 2 mmol litre -1 . Before the experiment proper, the medium was heated to 37°C overnight and pH adjusted to 7.3-7.35. Stock solutions of propofol (1% Diprivan) and 10% Intralipid (Kabi Pharma AB, Stockholm, Sweden) were diluted in the running medium immediately before the experiment. Cells were perfused with the running medium at 100 µl min -1 for 130 s, followed by 30 s during which flow was stopped. The flow-on/flow-off cycle was controlled by a Macintosh computer interface. During the flow-off periods, cells acidify the medium and the rate of chamber acidification was measured. Two measurements were made and the higher of the two was taken as the change in acidification rate. Average acidification rates from pooled data of three independent experiments were compared by ANOVA and Tukey's post hoc analysis. Figure 1 shows the cellular responses to stimulation with propofol and Intralipid, expressed as mean (SEM) per cent of baseline extracellular acidification rates. Propofol produced a concentration-dependent reversible reduction in extracellular acidification rate. Propofol 3 µg ml -1 caused a mean decrease of 1.51 (SEM 0.71)% which was significantly greater than that produced by propofol 0.3 µg ml -1 or Intralipid alone (PϽ0.05). The response after stimulation 468 with propofol 30 µg ml -1 was a decrease of 4.68 (0.35)% and this was significantly greater than that elicited by propofol 3 or 0.3 µg ml -1 , or Intralipid (PϽ0.001).
Comment
This is the first study to demonstrate real-time inhibition of extracellular acidification rate in primary cortical cell cultures by propofol. The acidification rate comprises the sum of all cellular processes producing acid extrusion. In most cells, this measure constitutes respiration, ATP hydrolysis, carbon dioxide production, lactic acid released during glycolysis and proton extrusion by mechanisms unrelated to energy metabolism. Propofol anaesthesia is known to decrease local cerebral glucose use in the rat 6 and our observations may be related to a decrease in the rate of ATP consumption secondary to a reduction in ATP production. In addition, propofol reduces cerebral oxygen consumption and electrical activity, and the decrease in acidification could reflect a reduction in ATP consumption because of a decrease in energy metabolism. Both of these phenomena are consistent with the observation that propofol attenuates ATP depletion during anoxia in vitro 7 and our findings provide evidence of propofol-induced reduction in cellular catabolism and excretion of the acidic by-products of metabolism.
The rate of change in pH in tissue culture extracellular fluid is a function of the cell concentration and rate of proton excretion per cell. Therefore, it is possible that inhibition of extracellular acidification may have been related to reduction in the number of viable cells (because of cell loss) from cellular damage induced by mechanical stresses during perfusion in the flow chamber or secondary to protracted perfusion with the low-buffering capacity medium. Although we did not measure lactate dehydrogenase activity in the cell cultures as an index of cell viability, the dose-dependent and strong temporal relationship between propofol stimulation and extracellular alkalinization suggests that our findings are not attributable to this confounding variable. Similarly, we maintained glucose concentrations constant in the running medium as it has been suggested that a decrease in substrate availability produces a decrease in metabolic activity. This would be manifest as a decline in the rate of extracellular acidification.
Finally, in common with other in vitro studies examining the effects of anaesthetic agents on central neurones in cell culture, extrapolation to the clinical setting is limited by the paucity of information on the concentrations of i.v. anaesthetics in and around the human brain during anaesthesia. We have demonstrated previously that the pseudo-steady-state concentration of propofol in human cerebrospinal fluid during maintenance propofol anaesthesia in neurosurgical patients is only 35 ng ml -1 . 8 Our study, while confirming the cerebral metabolic depressant effect of propofol, demonstrated that much higher concentrations (3-30 µg ml -1 ) are required to produce a significant decrease in the extracellular acidification rate in rodent cortical neurones. Together, these findings suggest that the distribution of propofol in the biophase in rats and humans is markedly different. In addition, they highlight the pitfalls inherent in applying in vitro models of pharmacological neuroprotection to clinical anaesthesia.
